High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
Authors
Keywords
Cytokines, Non-small cell lung cancer, Lung and intrathoracic tumors, Cancer treatment, Prognosis, Inflammation, Cancer detection and diagnosis, Differentiated tumors
Journal
PLoS One
Volume 12, Issue 7, Pages e0181125
Publisher
Public Library of Science (PLoS)
Online
2017-07-18
DOI
10.1371/journal.pone.0181125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer
- (2016) Ángela Marrugal et al. DISEASE MARKERS
- Classification and Pathology of Lung Cancer
- (2016) Min Zheng Surgical Oncology Clinics of North America
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Trial Watch—Immunostimulation with cytokines in cancer therapy
- (2015) Erika Vacchelli et al. OncoImmunology
- Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells
- (2015) Juan Li et al. Oncotarget
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Role of Human Papilloma Virus (HPV) Infection in Non-Anogenital Cancer and the Promise of Immunotherapy: A Review
- (2014) Chris Cobos et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer
- (2013) C. Bodelon et al. ANNALS OF ONCOLOGY
- Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer
- (2013) Deepa Rangachari et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Circulating Inflammation Markers and Prospective Risk for Lung Cancer
- (2013) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?
- (2012) M. Reck ANNALS OF ONCOLOGY
- Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
- (2012) Chin Hao Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Significance of the Correlation Between the Expression of Interleukin 6 and Clinical Features in Patients With Non-Small Cell Lung Cancer
- (2012) Eitetsu Koh et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- C-Reactive Protein, Interleukin 6 and Lung Cancer Risk: A Meta-Analysis
- (2012) Bo Zhou et al. PLoS One
- IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
- (2011) Jiankun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival
- (2010) Chunxia Su et al. MEDICAL ONCOLOGY
- Blood Cytokines as Biomarkers of In Vivo Toxicity in Preclinical Safety Assessment: Considerations for Their Use
- (2010) Jacqueline M. Tarrant TOXICOLOGICAL SCIENCES
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
- (2009) Natalia Martin-Orozco et al. IMMUNITY
- Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers
- (2009) J. Sunyer et al. NICOTINE & TOBACCO RESEARCH
- Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma
- (2008) W.-C. Liao et al. CLINICAL CANCER RESEARCH
- Cytokines as a key component of cancer-related inflammation
- (2008) Giovanni Germano et al. CYTOKINE
- Understanding the Chemical Properties of Macerals and Minerals in Coal and its Potential Application for Occupational Lung Disease Prevention
- (2008) Xi Huang et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- Cytokine-based transformation of immune surveillance into tumor-promoting inflammation
- (2008) J B Mumm et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started